{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T14:40:39Z","timestamp":1768142439780,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:00:00Z","timestamp":1601769600000},"content-version":"vor","delay-in-days":3108,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1194\/jlr.m021733","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T11:15:13Z","timestamp":1325848513000},"page":"664-673","source":"Crossref","is-referenced-by-count":15,"title":["Unusual binding of ursodeoxycholic acid to ileal bile acid binding protein: role in activation of FXR\u03b1"],"prefix":"10.1016","volume":"53","author":[{"given":"Changming","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian V.","family":"Filipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M021733_bib1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1194\/jlr.M021733_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.21337","article-title":"Primary sclerosing cholangitis: summary of a workshop","volume":"44","author":"LaRusso","year":"2006","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M021733_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1194\/jlr.M021733_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1194\/jlr.M021733_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/jnci\/dji144","article-title":"Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence","volume":"97","author":"Alberts","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1194\/jlr.M021733_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1665-2681(19)31949-0","article-title":"Biliary secretion and excretion in health and disease: current concepts","volume":"6","author":"Hofmann","year":"2007","journal-title":"Ann. Hepatol."},{"key":"10.1194\/jlr.M021733_bib7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/gut.52.9.1239","article-title":"Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry","volume":"52","author":"Hofmann","year":"2003","journal-title":"Gut."},{"key":"10.1194\/jlr.M021733_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell."},{"key":"10.1194\/jlr.M021733_bib9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science."},{"key":"10.1194\/jlr.M021733_bib10","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science."},{"key":"10.1194\/jlr.M021733_bib11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","article-title":"FXR, a multipurpose nuclear receptor","volume":"31","author":"Lee","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1194\/jlr.M021733_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.20294","article-title":"The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: hype or hope?","volume":"40","author":"Trauner","year":"2004","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M021733_bib13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","article-title":"Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1194\/jlr.M021733_bib14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/carcin\/bgl249","article-title":"Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice","volume":"28","author":"Kim","year":"2007","journal-title":"Carcinogenesis."},{"key":"10.1194\/jlr.M021733_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1023\/B:DDAS.0000034558.78747.98","article-title":"The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer","volume":"49","author":"De Gottardi","year":"2004","journal-title":"Dig. Dis. Sci."},{"key":"10.1194\/jlr.M021733_bib16","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.1158\/0008-5472.CAN-08-1791","article-title":"Nuclear bile acid receptor FXR protects against intestinal tumorigenesis","volume":"68","author":"Modica","year":"2008","journal-title":"Cancer Res."},{"key":"10.1194\/jlr.M021733_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.108.145409","article-title":"Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development","volume":"328","author":"Maran","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1194\/jlr.M021733_bib18","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1074\/jbc.M306422200","article-title":"The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion","volume":"279","author":"Lew","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M021733_bib19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00018-002-8490-y","article-title":"New insights into the structure and function of fatty acid-binding proteins","volume":"59","author":"Zimmerman","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1194\/jlr.M021733_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1357-2725(01)00070-X","article-title":"Ligand specificity and conformational stability of human fatty acid-binding proteins","volume":"33","author":"Zimmerman","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1194\/jlr.M021733_bib21","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1021\/bi0346502","article-title":"Steroid ring hydroxylation patterns govern cooperativity in human bile acid binding protein","volume":"42","author":"Tochtrop","year":"2003","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M021733_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/bi051781p","article-title":"Determinants of cooperativity and site selectivity in human ileal bile acid binding protein","volume":"45","author":"Toke","year":"2006","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M021733_bib23","doi-asserted-by":"crossref","first-page":"42283","DOI":"10.1074\/jbc.M507454200","article-title":"Ileal bile acid-binding protein, functionally associated with the farnesoid X receptor or the ileal bile acid transporter, regulates bile acid activity in the small intestine","volume":"280","author":"Nakahara","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M021733_bib24","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1073\/pnas.012379199","article-title":"Energetics by NMR: site-specific binding in a positively cooperative system","volume":"99","author":"Tochtrop","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M021733_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s11745-997-0099-8","article-title":"An improved synthesis of taurine- and glycine-conjugated bile acids","volume":"32","author":"Momose","year":"1997","journal-title":"Lipids."},{"key":"10.1194\/jlr.M021733_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbaexp.2003.09.008","article-title":"Human ileal bile acid-binding protein promoter and the effects of CDX2","volume":"1630","author":"Barley","year":"2003","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M021733_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1194\/jlr.M500417-JLR200","article-title":"FXR regulates organic solute transporters \u03b1 and \u03b2 in the adrenal gland, kidney, and intestine","volume":"47","author":"Lee","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M021733_bib28","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1158\/0008-5472.CAN-06-3690","article-title":"A novel variant of ileal bile acid binding protein is up-regulated through NF-\u03baB activation in colorectal adenocarcinoma","volume":"67","author":"Fang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1194\/jlr.M021733_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M021733_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/prot.10289","article-title":"Insights into the bile acid transportation system: the human ileal lipid-binding protein-cholyltaurine complex and its comparison with homologous structures","volume":"50","author":"Kurz","year":"2003","journal-title":"Proteins."},{"key":"10.1194\/jlr.M021733_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2169\/internalmedicine1962.28.25","article-title":"Distribution of tissue bile acids in the human alimentary tract and colon polyps","volume":"28","author":"Nakashima","year":"1989","journal-title":"Jpn. J. Med."},{"key":"10.1194\/jlr.M021733_bib32","first-page":"314","article-title":"Tissue bile acids in patients with colon cancer and colonic polyps","volume":"77","author":"Gelb","year":"1982","journal-title":"Am. J. Gastroenterol."},{"key":"10.1194\/jlr.M021733_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/abbi.1999.1295","article-title":"Small and large unilamellar vesicle membranes as model system for bile acid diffusion in hepatocytes","volume":"368","author":"Hofmann","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1194\/jlr.M021733_bib34","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0039-128X(96)00119-5","article-title":"Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification","volume":"61","author":"Aldini","year":"1996","journal-title":"Steroids."},{"key":"10.1194\/jlr.M021733_bib35","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1021\/ja047589c","article-title":"A single hydroxyl group governs ligand site selectivity in human ileal bile acid binding protein","volume":"126","author":"Tochtrop","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1194\/jlr.M021733_bib36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/003655202760230955","article-title":"Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers","volume":"37","author":"van Gorkom","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1194\/jlr.M021733_bib37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1158\/1055-9965.861.13.5","article-title":"Results of a phase I multiple-dose clinical study of ursodeoxycholic acid","volume":"13","author":"Hess","year":"2004","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1194\/jlr.M021733_bib38","doi-asserted-by":"crossref","first-page":"14072","DOI":"10.1021\/bi0489661","article-title":"Crystal structure of chicken liver basic fatty acid-binding protein complexed with cholic acid","volume":"43","author":"Nichesola","year":"2004","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M021733_bib39","doi-asserted-by":"crossref","first-page":"39307","DOI":"10.1074\/jbc.M111.261099","article-title":"Structural requirements for cooperativity in ileal bile acid-binding proteins","volume":"286","author":"Zanzoni","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M021733_bib40","doi-asserted-by":"crossref","first-page":"23695","DOI":"10.1074\/jbc.274.34.23695","article-title":"Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid","volume":"274","author":"Dong","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M021733_bib41","doi-asserted-by":"crossref","first-page":"29139","DOI":"10.1074\/jbc.M202923200","article-title":"Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells","volume":"277","author":"Huang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M021733_bib42","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/bi0352318","article-title":"Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor \u03b1 and enhances ligand distribution to nuclei of living cells","volume":"43","author":"Huang","year":"2004","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M021733_bib43","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.bcp.2005.03.019","article-title":"Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor","volume":"69","author":"Campana","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M021733_bib44","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1194\/jlr.M012542","article-title":"Studies in mice, hamsters, and rats demonstrate that repression of hepatic apoA-I expression by taurocholic acid in mice is not mediated by the farnesoid-X-receptor","volume":"52","author":"Gard\u00e8s","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M021733_bib45","first-page":"1263","article-title":"Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat","volume":"26","author":"Holzinger","year":"1997","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M021733_bib46","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.510280231","article-title":"Transport of fluorescent bile acids by the isolated perfused rat liver: kinetics, sequestration, and mobilization","volume":"28","author":"Holzinger","year":"1998","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M021733_bib47","doi-asserted-by":"crossref","first-page":"G54","DOI":"10.1152\/ajpgi.00592.2007","article-title":"Cytosol-nucleus traffic and colocalization with FXR of conjugated bile acids in rat hepatocytes","volume":"295","author":"Monte","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1194\/jlr.M021733_bib48","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/gut.52.9.1371","article-title":"Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration","volume":"52","author":"Lanzini","year":"2003","journal-title":"Gut."},{"key":"10.1194\/jlr.M021733_bib49","doi-asserted-by":"crossref","first-page":"G256","DOI":"10.1152\/ajpgi.00027.2007","article-title":"Human cecal bile acids: concentration and spectrum","volume":"293","author":"Hamilton","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1194\/jlr.M021733_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mrrev.2004.08.001","article-title":"Bile acids as carcinogens in human gastrointestinal cancers","volume":"589","author":"Bernstein","year":"2005","journal-title":"Mutat. Res."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520405607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520405607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M021733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T06:32:34Z","timestamp":1686637954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520405607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0022227520405607"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m021733","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}